187 related articles for article (PubMed ID: 31212980)
1. Toxin B Variants from
López-Ureña D; Orozco-Aguilar J; Chaves-Madrigal Y; Ramírez-Mata A; Villalobos-Jimenez A; Ost S; Quesada-Gómez C; Rodríguez C; Papatheodorou P; Chaves-Olarte E
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31212980
[No Abstract] [Full Text] [Related]
2. Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities.
Quesada-Gómez C; López-Ureña D; Chumbler N; Kroh HK; Castro-Peña C; Rodríguez C; Orozco-Aguilar J; González-Camacho S; Rucavado A; Guzmán-Verri C; Lawley TD; Lacy DB; Chaves-Olarte E
Infect Immun; 2016 Jan; 84(3):856-65. PubMed ID: 26755157
[TBL] [Abstract][Full Text] [Related]
3. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
5. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
7. Receptor Binding Domains of TcdB from
Henkel D; Tatge H; Schöttelndreier D; Tao L; Dong M; Gerhard R
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255261
[TBL] [Abstract][Full Text] [Related]
8. The role of toxin A and toxin B in the virulence of Clostridium difficile.
Carter GP; Rood JI; Lyras D
Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163
[TBL] [Abstract][Full Text] [Related]
9. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
[TBL] [Abstract][Full Text] [Related]
10. Transforming Growth Factor β1/SMAD Signaling Pathway Activation Protects the Intestinal Epithelium from Clostridium difficile Toxin A-Induced Damage.
Tinoco-Veras CM; Santos AAQA; Stipursky J; Meloni M; Araujo APB; Foschetti DA; López-Ureña D; Quesada-Gómez C; Leitão RFC; Gomes FCA; Brito GAC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784928
[No Abstract] [Full Text] [Related]
11. TcdB or not TcdB: a tale of two Clostridium difficile toxins.
Carter GP; Awad MM; Kelly ML; Rood JI; Lyras D
Future Microbiol; 2011 Feb; 6(2):121-3. PubMed ID: 21366410
[No Abstract] [Full Text] [Related]
12. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
Zhang Y; Hamza T; Gao S; Feng H
Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
[TBL] [Abstract][Full Text] [Related]
13. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
15. Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.
Devera TS; Lang GA; Lanis JM; Rampuria P; Gilmore CL; James JA; Ballard JD; Lang ML
Infect Immun; 2016 Jan; 84(1):194-204. PubMed ID: 26502913
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile toxins: mechanism of action and role in disease.
Voth DE; Ballard JD
Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
[TBL] [Abstract][Full Text] [Related]
17. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
18. Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium.
Kasendra M; Barrile R; Leuzzi R; Soriani M
J Infect Dis; 2014 Apr; 209(7):1095-104. PubMed ID: 24273043
[TBL] [Abstract][Full Text] [Related]
19. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
20. Extra-Intestinal Effects of
Tonon F; Di Bella S; Grassi G; Luzzati R; Ascenzi P; di Masi A; Zennaro C
Cells; 2020 Dec; 9(12):. PubMed ID: 33271969
[No Abstract] [Full Text] [Related]
[Next] [New Search]